TFS CAPITAL LLC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 41 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$47,000
-66.7%
68,317
-41.5%
0.01%
-53.3%
Q4 2015$141,000
-78.3%
116,773
-59.9%
0.02%
-76.2%
Q3 2015$649,000
+40.8%
291,022
+47.0%
0.06%
+40.0%
Q2 2015$461,000
+35.2%
197,961
+55.1%
0.04%
+50.0%
Q3 2014$341,000
-74.6%
127,615
-64.6%
0.03%
-71.7%
Q2 2014$1,344,000
-37.5%
360,260
+97.0%
0.11%
-25.4%
Q1 2014$2,151,000
+337.2%
182,883
+210.0%
0.14%
+517.4%
Q4 2013$492,00058,9960.02%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q2 2016.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders